Publications en biostatistique

  • Jacob L, Uvarova M, Boulet S, Begaj I, Chevret S. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials – an example in hemato-oncology. BMC Med Res Methodol. 2016 Jun 2;16(1):67. doi: 10.1186/s12874-016-0166-7.
  • Aboab J, Celi LA, Charlton P, Feng M, Ghassemi M, Marshall DC, Mayaud L, Naumann T, McCague N, Paik KE, Pollard TJ, Resche-Rigon M, Salciccioli JD, Stone DJ. A « datathon » model to support cross-disciplinary collaboration. Sci Transl Med. 2016 Apr 6;8(333):333ps8. doi: 10.1126/scitranslmed.aad9072. Review.
  • Galimard JE, Chevret S, Protopopescu C, Resche-Rigon M. A multiple imputation approach for MNAR mechanisms compatible with Heckman’s model. Stat Med. 2016 Feb 18. doi: 10.1002/sim.6902. [Epub ahead of print]
  • Moatti M, Chevret S, Zohar S, Rosenberger WF. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes. Methods Inf Med. 2016 Jan 8;55(1):4-13. doi: 10.3414/ME14-01-0132. Epub 2015 Sep 25.
  • Mebazaa A, Casadio MC, Azoulay E, Guidet B, Jaber S, Levy B, Payen D, Vicaut E, Resche-Rigon M, Gayat E. Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study. BMC Anesthesiol. 2015 Oct 12;15:143. doi: 10.1186/s12871-015-0129-2.
  • Moatti M, Chevret S, Zohar S, Rosenberger WF. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes. Methods Inf Med. 2015 Sep 25;54(5).
  • Ecotière L, Thierry A, Debiais-Delpech C, Chevret S, Javaugue V, Desport E, Belmouaz S, Quellard N, Kaaki S, Goujon JM, Fermand JP, Touchard G, Bridoux F. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients. Nephrol Dial Transplant. 2015 Aug 19. pii: gfv283.
  • Bailly S, Pirracchio R, Timsit JF. What’s new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists. Intensive Care Med. 2015 Jun 24.
  • Caruana E, Chevret S, Resche-Rigon M, Pirracchio R. A new weighted balance measure helped to select the variables to be included in a propensity score model. J Clin Epidemiol. 2015 May 1. pii: S0895-4356(15)00212-7. doi: 10.1016/j.jclinepi.2015.04.009.
  • Chevret S, Seaman S, Resche-Rigon M. Multiple imputation: a mature approach to dealing with missing data. Intensive Care Med. 2015 Feb;41(2):348-50. doi: 10.1007/s00134-014-3624-x
  • Pirracchio R, Petersen ML, Carone M, Rigon MR, Chevret S, van der Laan MJ. Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. Lancet Respir Med. 2015 Jan;3(1):42-52. doi: 10.1016/S2213-2600(14)70239-5.
  • Pirracchio R, Petersen ML, van der Laan M. Improving propensity score estimators’ robustness to model misspecification using super learner. Am J Epidemiol. 2015 Jan 15;181(2):108-19. doi: 10.1093
  • Lapidus N, Chevret S, Resche-Rigon M. Assessing assay agreement estimation for multiple left-censored data: a multiple imputation approach. Stat Med. 2014 Dec 30;33(30):5298-309. doi: 10.1002/sim.6319.
  • Pirracchio R, Petersen ML, van der Laan M. Improving Propensity Score Estimators’ Robustness to Model Misspecification Using Super Learner. Am J Epidemiol. 2014 Dec 16. pii: kwu253
  • Pirracchio R, Petersen ML, Carone M, Rigon MR, Chevret S, van der Laan MJ. Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. Lancet Respir Med. 2014 Nov 24. pii: S2213-2600(14)70239-5. doi: 10.1016/S2213-2600(14)70239-5.
  • Pibouleau L, Chevret S. AN INTERNET-BASED METHOD TO ELICIT EXPERTS’ BELIEFS FOR BAYESIAN PRIORS: A CASE STUDY IN INTRACRANIAL STENT EVALUATION. Int J Technol Assess Health Care. 2014 Nov 17:1-8.
  • Lapidus N, Chevret S, Resche-Rigon M. Assessing assay agreement estimation for multiple left-censored data: a multiple imputation approach. Stat Med. 2014 Oct 8. doi: 10.1002/sim.6319.
  • Pibouleau L, Chevret S. An internet-based method to elicit experts’ beliefs for Bayesian priors. International Journal of Technology Assessment in Health Care (in press)
  • Chevret S. Propensity-matching analysis is not straightforward. Am J Respir Crit Care Med. 2014 Aug 15;190(4):362-4
  • Pirracchio R, Ranzani OT. Recalibrating our prediction models in the ICU: time to move from the abacus to the computer. Intensive Care Med. 2014 Mar;40(3):438-41.
  • Pirracchio R, Ranzani OT. Recalibrating our prediction models in the ICU: time to move from the abacus to the computer. Intensive Care Med. 2014 Feb 14
  • Lambert J, Chevret S. Summary measure of discrimination in survival models based on cumulative/dynamic time-dependent ROC curves. Stat Methods Med Res. 2014 Jan 5.
  • Sarkozy C, Terré C, Jardin F, Radford I, Roche-Lestienne C, Penther D, Bastard C, Rigaudeau S, Pilorge S, Morschhauser F, Bouscary D, Delarue R, Farhat H, Rousselot P, Hermine O, Tilly H, Chevret S, Castaigne S. Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index. Genes Chromosomes Cancer. 2014 Jan;53(1):106-16.
  • Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J, Zannad F, Alla F, Mebazaa A; for the GREAT network. Correction: The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis. PLoS One. 2013 Dec 10;8(12).
  • Pirracchio R, Carone M, Rigon MR, Caruana E, Mebazaa A, Chevret S. Propensity score estimators for the average treatment effect and the average treatment effect on the treated may yield very different estimates. Stat Methods Med Res. 2013 Nov 6.
  • Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Schnell P, Bernhardt CA, Mary JY, Sandborn WJ. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013 Nov;145(5):987-95.
  • Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J, Zannad F, Alla F, Mebazaa A; GREAT network. The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One. 2013 Aug 15;8(8):e71659
  • Resche-Rigon M, White IR, Bartlett JW, Peters SA, Thompson SG; on behalf of the PROG-IMT Study Group. Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data. Stat Med. 2013 Jul 16.
  • Moatti M, Zohar S, Facon T, Moreau P, Mary JY, Chevret S. Modeling of experts’ divergent prior beliefs for a sequential phase III clinical trial. Clin Trials. 2013 Jul 2.
  • Kant A, Gupta PK, Zohar S, Chevret S, Hopkins PM. Application of the Continual Reassessment Method to Dose-finding Studies in Regional Anesthesia: An Estimate of the ED95 Dose for 0.5% Bupivacaine for Ultrasound-guided Supraclavicular Block. Anesthesiology. 2013 Jul;119(1):29-35.
  • Gayat E, Thabut G, Christie JD, Mebazaa A, Mary JY, Porcher R. Within-center matching performed better when using propensity score matching to analyze multicenter survival data: empirical and Monte Carlo studies. J Clin Epidemiol. 2013 Jun 22.
  • Burgess S, White IR, Resche-Rigon M, Wood AM. Combining multiple imputation and meta-analysis with individual participant data. Stat Med. 2013 May 24.
  • Gupta PK, Chevret S, Zohar S, Hopkins PM. What is the ED95 of prilocaine for femoral nerve block using ultrasound? Br J Anaesth. 2013 May;110(5):831-6.
  • Pibouleau L, Chevret S. Bayesian hierarchical meta-analysis model for medical device evaluation: application to intracranial stents. Int J Technol Assess Health Care. 2013 Apr;29(2):123-30.
  • Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2013 Feb 1;187(3):276-85.
  • Pirracchio R, Resche Rigon M, Mebazaa A, Zannad F, Alla F, Chevret S. Continuous positive airway pressure (CPAP) may not reduce short-term mortality in cardiogenic pulmonary edema: a propensity-based analysis. J Card Fail. 2013 Feb;19(2):108-16.
  • Zohar S, Resche-Rigon M, Chevret S. Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study. Clin Trials. 2013;10(3):414-21.
  • Redondo YT, Lambert J, Chevret S. A minimal net reclassification improvement to assess predictions of intensive care mortality. Stat Methods Med Res. 2012 Oct 14.
  • Resche-Rigon M, Pirracchio R, Robin M, De Latour RP, Sibon D, Ades L, Ribaud P, Fermand JP, Thieblemont C, Socié G, Chevret S. Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases. BMC Blood Disord.2012 Aug 16;12:10.
  • Pirracchio R, Resche-Rigon M, Chevret S. Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size. BMC Med Res Methodol. 2012 May 30;12:70.
  • Chevret S. Bayesian adaptive clinical trials: a dream for statisticians only? Stat Med. 2012 May 20;31(11-12):1002-13.
  • Gayat E, Resche-Rigon M, Mary JY, Porcher R. Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study. Pharm Stat. 2012 Mar 12.
  • Sprung CL, Artigas A, Kesecioglu J, Pezzi A, Wiis J, Pirracchio R, Baras M, Edbrooke DL, Pesenti A, Bakker J, Hargreaves C, Gurman G, Cohen SL, Lippert A, Payen D, Corbella D, Iapichino G. The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: intensive care benefit for the elderly. Crit Care Med. 2012 Jan;40(1):132-8.
  • Pirracchio R, Sprung CL, Payen D, Chevret S. Utility of time-dependent inverse-probability-of-treatment weights to analyze observational cohorts in the intensive care unit. J Clin Epidemiol. 2011 Dec;64(12):1373-82.
  • Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vésin A, Garrouste-Orgeas M, Decruyenaere J, Clec’h C, Azoulay E, Benoit D; Outcomerea Study Group. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1133-9.
  • Timsit JF, Zahar JR, Chevret S. Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care. 2011 Oct;17(5):464-71.
  • Pirracchio R, Sprung C, Payen D, Chevret S. Benefits of ICU admission in critically ill patients: whether instrumental variable methods or propensity scores should be used. BMC Med Res Methodol. 2011 Sep 21;11:132.
  • Seegers V, Chevret S, Resche-Rigon M. Dose-finding design driven by efficacy in onco-hematology phase I/II trials. Stat Med. 2011 Jun 15;30(13):1574-83.
  • Terrier B, Semoun O, Saadoun D, Sène D, Resche-Rigon M, Cacoub P. Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum. 2011 Jun;63(6):1748-57.
  • Valet F, Mary JY. Power estimation of tests in log-linear non-uniform association models for ordinal agreement. BMC Med Res Methodol. 2011 May 17;11:70.
  • Pibouleau L, Chevret S. Bayesian statistical method was underused despite its advantages in the assessment of implantable medical devices. J Clin Epidemiol. 2011 Mar;64(3):270-9.
  • Karlin L, Arnulf B, Chevret S, Ades L, Robin M, De Latour RP, Malphettes M, Kabbara N, Asli B, Rocha V, Fermand JP, Socie G. Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy. Bone Marrow Transplant. 2011 Feb;46(2):250-6.
  • Clec’h C, Gonzalez F, Lautrette A, Nguile-Makao M, Garrouste-Orgeas M, Jamali S, Golgran-Toledano D, Descorps-Declere A, Chemouni F, Hamidfar-Roy R, Azoulay E, Timsit JF. Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis. Crit Care. 2011;15(3):R128.
  • Gayat E, Pirracchio R, Resche-Rigon M, Mebazaa A, Mary JY, Porcher R. Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med. 2010 Dec;36(12):1993-2003.
  • Resche-Rigon M, S Zohar, Chevret S. Maximum-relevance weighted likelihood estimator: Application to the continual reassessment method. Statistics and its interface 2010; 3 (2):. 177-184
  • Deslandes E, Chevret S. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data. BMC Med Res Methodol. 2010 Jul 29;10:69.
  • Cottrell G, Cot M, Mary JY. [Multiple imputation of missing at random data: General points and presentation of a Monte-Carlo method]. Rev Epidemiol Sante Publique. 2009 Oct;57(5):361-72.
  • Hiance A, Chevret S, Lévy V. A practical approach for eliciting expert prior beliefs about cancer survival in phase III randomized trial. J Clin Epidemiol.2009 Apr;62(4):431-437.
  • Katsahian S, Latouche A, Mary JY, Chevret S, Porcher R. Practical methodology of meta-analysis of individual patient data using a survival outcome. Contemp Clin Trials. 2008 Mar;29(2):220-30.
  • Deslandes E, Chevret S. Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: application to clinical trial data on chronic lymphocytic leukaemia.Stat Med . 2007 30 déc; 26 (30) :5411-21